FEBS Letters · 2019 · 89 citations · 37 references
Life SciencesBiochemistryMolecular BiologyDementiaLipid BiochemistryNeurodegenerationAlzheimer DiseaseAmyloid FormationLipid MetabolismLipoprotein MetabolismNeurodegenerative DiseasesProtein AggregationAmyloid Beta AggregationAmyloid Beta PathwaysAmyloid Beta PeptidesApolipoprotein FunctionApolipoprotein Metabolism
Apolipoprotein E (APOE) genotype determines Alzheimer's disease (AD) susceptibility, with the APOE ε4 allele being an established risk factor for late-onset AD. The ApoE lipidation status has been reported to impact amyloid-beta (Aβ) peptide metabolism. The details of how lipidation affects ApoE behavior remain to be elucidated. In this study, we prepared lipid-free and lipid-bound ApoE particles, mimicking the high-density lipoprotein particles found in vivo, for all three isoforms (ApoE2, ApoE3, and ApoE4) and biophysically characterized them. We find that lipid-free ApoE in solution has the tendency to aggregate in vitro in an isoform-dependent manner under near-physiological conditions and that aggregation is impeded by lipidation of ApoE.
37
Warren J. Strittmatter, Ann M. Saunders, D. E. Schmechel et al. · Proceedings of the National Academy of Sciences · 1993 · 4.3K citations · Full text
Life Sciences, Genetics, Neurology +17
Yoshio Namba, Masanori Tomonaga, Hiroshi Kawasaki et al. · Brain Research · 1991 · 1.2K citations